Skip to content

Acupuncture in the treatment of Early-Onset Parkinson's Disease: A Prospective Randomized Controlled Clinical Study

Acupuncture in the treatment of Early-Onset Parkinson's Disease: A Prospective Randomized Controlled Clinical Study

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400084946
Enrollment
Unknown
Registered
2024-05-28
Start date
2024-06-01
Completion date
Unknown
Last updated
2024-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early onset Parkinson's disease

Interventions

verum acupuncture group:basic pharmacotherapy+verum acupuncture
sham acupuncture group:basic pharmacotherapy+sham acupuncture
wait-list group:basic pharmacotherapy

Sponsors

The First Affiliated Hospital of Guangzhou University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 49 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for Parkinson's disease; 2. Age 25-49 years; 3. Hoehn-Yahr stage 1-4; 4. Clear consciousness, stable vital signs, and able to communicate normally; 5. Willing to sign an informed consent form.

Exclusion criteria

Exclusion criteria: (1) Parkinson's syndrome caused by various causes such as cerebrovascular disease, poisoning, progressive supranuclear palsy, multiple system atrophy, lewy body dementia and corticobasal ganglia degeneration; (2) Those with more serious diseases, such as serious liver and kidney, blood, tumors, endocrine diseases or pain; (3) Participants in clinical trials of other drugs and acupuncture at the same time; (4) mental patients; (5) People who are deaf or have communication disabilities; (6) A history of alcoholism or drug abuse; (7) Women who are pregnant or planning to become pregnant.

Design outcomes

Primary

MeasureTime frame
Unified Parkinson's Disease Rating Scale;

Secondary

MeasureTime frame
Parkinson's disease non-motor Symptom Assessment Scale;Parkinson’s Disease Daily Quality of Life-39 ;Synapsys human posture balance system;3D gait analysis;Musculoskeletal ultrasound;Resting-state functional magnetic resonance imaging;Diffusion tensor imaging;Proton magnetic resonance spectroscopy;

Countries

China

Contacts

Public ContactNanbu Wang

State Key Laboratory of Traditional Chinese Medicine Syndrome, The First Affiliated Hospital of Guangzhou University of Chinese Medicine

nanbuwang@gzucm.edu.cn+86 139 0306 3126

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026